• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
CRISPR Editing Technology in Biological and Biomedical Investigation.生物与生物医学研究中的CRISPR编辑技术
J Cell Biochem. 2017 Nov;118(11):3586-3594. doi: 10.1002/jcb.26099. Epub 2017 Jul 4.
2
Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.CRISPR/Cas9 RNA 导向的核酸酶基因编辑。
Circ Res. 2017 Mar 3;120(5):876-894. doi: 10.1161/CIRCRESAHA.116.309727.
3
The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.CRISPR/Cas9 基因组编辑技术在抗击人类致癌病毒中的意义。
J Med Virol. 2019 Jan;91(1):1-13. doi: 10.1002/jmv.25292. Epub 2018 Sep 24.
4
Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.CRISPR/Cas技术在生物学和生物医学研究中的进展与应用
J Cell Biochem. 2017 Oct;118(10):3061-3071. doi: 10.1002/jcb.26198. Epub 2017 Jun 30.
5
CRISPR/Cas9 Immune System as a Tool for Genome Engineering.CRISPR/Cas9免疫系统作为基因组工程的一种工具
Arch Immunol Ther Exp (Warsz). 2017 Jun;65(3):233-240. doi: 10.1007/s00005-016-0427-5. Epub 2016 Oct 3.
6
[Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].成簇规律间隔短回文重复序列(CRISPR)/CRISPR相关蛋白9系统在干细胞研究中的应用进展
Zhonghua Shao Shang Za Zhi. 2018 Apr 20;34(4):253-256. doi: 10.3760/cma.j.issn.1009-2587.2018.04.013.
7
Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research.CRISPR/Cas9 技术在癌症研究中 miRNA 编辑的新兴作用
Cancer Res. 2017 Dec 15;77(24):6812-6817. doi: 10.1158/0008-5472.CAN-17-2142. Epub 2017 Dec 5.
8
genome editing thrives with diversified CRISPR technologies.基因组编辑在多样化的 CRISPR 技术中蓬勃发展。
Zool Res. 2018 Mar 18;39(2):58-71. doi: 10.24272/j.issn.2095-8137.2017.012.
9
CRISPR-Cas9 technology: applications and human disease modelling.CRISPR-Cas9技术:应用与人类疾病建模
Brief Funct Genomics. 2017 Jan;16(1):4-12. doi: 10.1093/bfgp/elw025. Epub 2016 Jun 26.
10
Engineered CRISPR Systems for Next Generation Gene Therapies.用于下一代基因治疗的工程化CRISPR系统
ACS Synth Biol. 2017 Sep 15;6(9):1614-1626. doi: 10.1021/acssynbio.7b00011. Epub 2017 Jun 7.

引用本文的文献

1
Aquaporin-3 Downregulation in Vitiligo Keratinocytes Increases Oxidative Stress of Melanocytes.白癜风角质形成细胞中水通道蛋白-3的下调增加了黑素细胞的氧化应激。
Biomol Ther (Seoul). 2023 Nov 1;31(6):648-654. doi: 10.4062/biomolther.2023.112. Epub 2023 Oct 11.
2
Acceleration of the Deamination of Cytosine through Photo-Crosslinking.通过光交联加速胞嘧啶脱氨作用
Curr Issues Mol Biol. 2023 May 29;45(6):4687-4700. doi: 10.3390/cimb45060298.
3
Exosome engineering in cell therapy and drug delivery.细胞治疗和药物递送中的外泌体工程。
Inflammopharmacology. 2023 Feb;31(1):145-169. doi: 10.1007/s10787-022-01115-7. Epub 2023 Jan 7.
4
Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies.深入了解持续性HIV-1感染与功能性治愈:新能力与策略
Front Microbiol. 2022 Apr 27;13:862270. doi: 10.3389/fmicb.2022.862270. eCollection 2022.
5
Livestock and Risk Group 4 Pathogens: Researching Zoonotic Threats to Public Health and Agriculture in Maximum Containment.牲畜和风险组 4 病原体:在最高遏制条件下研究对公共卫生和农业的人畜共患病威胁。
ILAR J. 2022 Jan 7;61(1):86-102. doi: 10.1093/ilar/ilab029.
6
Gene editing and elimination of latent herpes simplex virus in vivo.体内基因编辑和潜伏单纯疱疹病毒的消除。
Nat Commun. 2020 Aug 18;11(1):4148. doi: 10.1038/s41467-020-17936-5.
7
Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine.囊性纤维化的新兴治疗方法。从基因编辑到个性化医疗。
Front Pharmacol. 2019 Feb 27;10:121. doi: 10.3389/fphar.2019.00121. eCollection 2019.
8
Gene Therapy Approaches to Functional Cure and Protection of Hematopoietic Potential in HIV Infection.基因治疗方法在HIV感染中实现功能性治愈和保护造血潜能
Pharmaceutics. 2019 Mar 11;11(3):114. doi: 10.3390/pharmaceutics11030114.
9
CRISPR/Cas9-Mediated Treatment Ameliorates the Phenotype of the Epidermolytic Palmoplantar Keratoderma-like Mouse.CRISPR/Cas9介导的治疗改善了表皮松解性掌跖角化病样小鼠的表型。
Mol Ther Nucleic Acids. 2018 Sep 7;12:220-228. doi: 10.1016/j.omtn.2018.05.005. Epub 2018 Jun 2.
10
GM insect pests under the Brazilian regulatory framework: development and perspectives.巴西监管框架下的转基因害虫:发展与展望
BMC Proc. 2018 Jul 19;12(Suppl 8):16. doi: 10.1186/s12919-018-0107-z. eCollection 2018.

本文引用的文献

1
In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.在动物模型中通过saCas9和多重单向导RNA对HIV-1前病毒进行体内切除
Mol Ther. 2017 May 3;25(5):1168-1186. doi: 10.1016/j.ymthe.2017.03.012. Epub 2017 Mar 30.
2
Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice.AAV 递送的 CRISPR/Cas9 基因敲除可预防小鼠视网膜变性。
Nat Commun. 2017 Mar 14;8:14716. doi: 10.1038/ncomms14716.
3
CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.CRISPR-Cas9 系统驱动单纯疱疹病毒基因组的位点特异性选择压力。
Virus Res. 2018 Jan 15;244:286-295. doi: 10.1016/j.virusres.2017.03.010. Epub 2017 Mar 6.
4
Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.CRISPR/Cas9 RNA 导向的核酸酶基因编辑。
Circ Res. 2017 Mar 3;120(5):876-894. doi: 10.1161/CIRCRESAHA.116.309727.
5
Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.通过CRISPR/Cas9介导的基因校正逆转亨廷顿病患者来源的诱导多能干细胞中的表型异常
Stem Cell Reports. 2017 Mar 14;8(3):619-633. doi: 10.1016/j.stemcr.2017.01.022. Epub 2017 Feb 23.
6
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni.利用源自空肠弯曲菌的小 Cas9 直系同源物进行体内基因组编辑。
Nat Commun. 2017 Feb 21;8:14500. doi: 10.1038/ncomms14500.
7
Novel AIDS therapies based on gene editing.基于基因编辑的新型艾滋病疗法。
Cell Mol Life Sci. 2017 Jul;74(13):2439-2450. doi: 10.1007/s00018-017-2479-z. Epub 2017 Feb 16.
8
Cas9, Cpf1 and C2c1/2/3-What's next?Cas9、Cpf1 和 C2c1/2/3——接下来是什么?
Bioengineered. 2017 May 4;8(3):265-273. doi: 10.1080/21655979.2017.1282018. Epub 2017 Jan 31.
9
Modification of the Genome of Domestic Animals.家畜基因组的修饰
Anim Biotechnol. 2017 Jul 3;28(3):198-210. doi: 10.1080/10495398.2016.1261874. Epub 2017 Jan 19.
10
Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus.利用 CRISPR/Cas 介导的基因编辑治疗乙型肝炎病毒和丙型肝炎病毒感染的研究进展。
Virus Res. 2018 Jan 15;244:311-320. doi: 10.1016/j.virusres.2017.01.003. Epub 2017 Jan 10.

生物与生物医学研究中的CRISPR编辑技术

CRISPR Editing Technology in Biological and Biomedical Investigation.

作者信息

White Martyn K, Kaminski Rafal, Young Won-Bin, Roehm Pamela C, Khalili Kamel

机构信息

Center for Neurovirology and Comprehensive NeuroAIDS Center, Department of Neuroscience, Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, Pennsylvania, 19140.

出版信息

J Cell Biochem. 2017 Nov;118(11):3586-3594. doi: 10.1002/jcb.26099. Epub 2017 Jul 4.

DOI:10.1002/jcb.26099
PMID:28460414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5682924/
Abstract

The CRISPR or clustered regularly interspaced short palindromic repeats system is currently the most advanced approach to genome editing and is notable for providing an unprecedented degree of specificity, effectiveness, and versatility in genetic manipulation. CRISPR evolved as a prokaryotic immune system to provide an acquired immunity and resistance to foreign genetic elements such as bacteriophages. It has recently been developed into a tool for the specific targeting of nucleotide sequences within complex eukaryotic genomes for the purpose of genetic manipulation. The power of CRISPR lies in its simplicity and ease of use, its flexibility to be targeted to any given nucleotide sequence by the choice of an easily synthesized guide RNA, and its ready ability to continue to undergo technical improvements. Applications for CRISPR are numerous including creation of novel transgenic cell animals for research, high-throughput screening of gene function, potential clinical gene therapy, and nongene-editing approaches such as modulating gene activity and fluorescent tagging. In this prospect article, we will describe the salient features of the CRISPR system with an emphasis on important drawbacks and considerations with respect to eliminating off-target events and obtaining efficient CRISPR delivery. We will discuss recent technical developments to the system and we will illustrate some of the most recent applications with an emphasis on approaches to eliminate human viruses including HIV-1, JCV and HSV-1 and prospects for the future. J. Cell. Biochem. 118: 3586-3594, 2017. © 2017 Wiley Periodicals, Inc.

摘要

CRISPR(成簇规律间隔短回文重复序列)系统是目前基因组编辑领域最先进的方法,其在基因操作中具有前所未有的特异性、有效性和多功能性,因而备受瞩目。CRISPR最初作为原核生物的免疫系统而进化,用于提供获得性免疫,抵抗诸如噬菌体等外来遗传元件。最近,它已发展成为一种用于特异性靶向复杂真核基因组中核苷酸序列以进行基因操作的工具。CRISPR的强大之处在于其简单易用,通过选择易于合成的向导RNA可灵活靶向任何给定的核苷酸序列,并且能够持续进行技术改进。CRISPR的应用广泛,包括创建用于研究的新型转基因细胞动物、高通量筛选基因功能、潜在的临床基因治疗以及诸如调节基因活性和荧光标记等非基因编辑方法。在这篇前瞻性文章中,我们将描述CRISPR系统的显著特征,重点关注在消除脱靶事件和实现高效CRISPR递送方面的重要缺点及注意事项。我们将讨论该系统最近的技术发展,并举例说明一些最新应用,重点是消除包括HIV-1、JCV和HSV-1在内的人类病毒的方法以及未来前景。《细胞生物化学杂志》118: 3586 - 3594, 2017。© 2017威利期刊公司